<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36983936</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>14</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>Severe Course of COVID-19 and Long-COVID-19 in Children: Difficulties in Diagnosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">781</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life13030781</ELocationID><Abstract><AbstractText>The question of COVID-19 and long-COVID-19 course in children remains unsolved. This infection in children, which is associated with COVID-19, can vary from asymptomatic to systemic damage of various systems. Multisystem inflammatory syndrome in children, associated with SARS-CoV-2 (MIS-C), is a serious condition in children and adolescents after experiencing COVID-19. Published data on MIS-C have indicated that the inflammation can be registered in the gastrointestinal tract (60-100%), as well as in cardiovascular (80%), nervous (29-58%), and respiratory (21-65%) systems. However, with the changing characteristics of SARS-CoV-2, the manifestations of COVID-19 and long-COVID-19 in children have also been changing. Currently, there is no clear understanding of the development of severe COVID-19 and MIS-C in children, especially after being exposed to patients with COVID-19. We presented two new clinical courses of multisystem inflammatory syndrome in children with severe multisystem damage after close contact to relatives with COVID-19 or long-COVID-19. Thus, high-risk children, who are positive for SARS-CoV-2 infection after contact with COVID-19 patients, should be clinically managed during the first few months. The identification of the disease complexity requires the involvement of neurologists, cardiologists, and other specialists.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vasichkina</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7336-4102</Identifier><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, St. Petersburg 197341, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kofeynikova</LastName><ForeName>Olga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, St. Petersburg 197341, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fetisova</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, St. Petersburg 197341, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Starshinova</LastName><ForeName>Anastasia Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Medical Department, Saint Petersburg State Pediatric Medical University, St. Petersburg 194100, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheyanova</LastName><ForeName>Elizaveta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, St. Petersburg 197341, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vershinina</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, St. Petersburg 197341, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryzhkov</LastName><ForeName>Anton</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, St. Petersburg 197341, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skripnik</LastName><ForeName>Aleksey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, St. Petersburg 197341, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alekseeva</LastName><ForeName>Daria</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1751-1424</Identifier><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, St. Petersburg 197341, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>H.Turner National Medical Research Center for Children's Orthopedics and Trauma Surgery, St. Petersburg 196603, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nechaeva</LastName><ForeName>Elizaveta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, St. Petersburg 197341, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glushkova</LastName><ForeName>Anzhela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology, St. Petersburg 192019, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kudlay</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1878-4467</Identifier><AffiliationInfo><Affiliation>Pharmacology Department, I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow 119435, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SSC Immunology Institute, FMBA Russia, Moscow 115552, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pervunina</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, St. Petersburg 197341, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Starshinova</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, St. Petersburg 197341, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>075-15-2022-301</GrantID><Agency>Federal Almazov North-West Medical Research Centre</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cardiovascular inflammation</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">coronavirus infection</Keyword><Keyword MajorTopicYN="N">long-COVID-19</Keyword><Keyword MajorTopicYN="N">multisystem inflammatory syndrome in children</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>1</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36983936</ArticleId><ArticleId IdType="pmc">PMC10056761</ArticleId><ArticleId IdType="doi">10.3390/life13030781</ArticleId><ArticleId IdType="pii">life13030781</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Starshinova A.A., Kushnareva E.A., Malkova A.M., Dovgalyuk I.F., Kudlay D.A. New coronavirus infection: Features of the clinical course, the possibilities of diagnosis, treatment and prevention of infection in adults and children. Quest. Mod. Pediatr. 2020;19:42&#x2013;50.</Citation></Reference><Reference><Citation>WHO  . Coronavirus Disease (COVID-19) Pandemic. WHO; Geneva, Switzerland: 2020.  [(accessed on 1 March 2020)].  Available online:  https://www.who.int/emergencies/diseases/novel-coronavirus-2019.</Citation></Reference><Reference><Citation>Liu K., Fang Y.Y., Deng Y., Liu W., Wang M.F., Ma J.P., Xiao W., Wang Y.N., Zhong M.H., Li C.H., et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin. Med. J. 2020;133:1025&#x2013;1031. doi: 10.1097/CM9.0000000000000744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000000744</ArticleId><ArticleId IdType="pmc">PMC7147277</ArticleId><ArticleId IdType="pubmed">32044814</ArticleId></ArticleIdList></Reference><Reference><Citation>Kompaniyets L., Bull-Otterson L., Boehmer K.T., Sarah Baca S., Alvarez P., Hong K., Hsu J., Harris A.M., Gundlapalli A.V., Saydah S. Post&#x2013;COVID-19 Symptoms and Conditions Among Children and Adolescents&#x2014;United States, 1 March 2020&#x2013;31 January 2022. MMWR. 2022;71:993&#x2013;999. doi: 10.15585/mmwr.mm7131a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7131a3</ArticleId><ArticleId IdType="pmc">PMC9368731</ArticleId><ArticleId IdType="pubmed">35925799</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova A.M., Kudlay D.A., Kudryavtsev I.V., Starshinova A.A., Yablonsky P.K., Shoenfeld Y. Immunogenetic predictors of severe COVID-19. Vaccines. 2021;9:211. doi: 10.3390/vaccines9030211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9030211</ArticleId><ArticleId IdType="pmc">PMC8001669</ArticleId><ArticleId IdType="pubmed">33802310</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Berger N.A., Kaelber D.C., Pamela BDavis P.B., Volkow N.D., Xu R. Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of Omicron. medRxiv. 2022 doi: 10.1101/2021.12.30.21268495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.30.21268495</ArticleId></ArticleIdList></Reference><Reference><Citation>Price A.M., Olson S.M., Newhams M.M., Halasa N.B., Boom J.A., Sahni L.C., Pannaraj P.S., Irby K., Bline K.E., Maddux A.B., et al. BNT162b2 Protection against the Omicron Variant in Children and Adolescents. N. Engl. J. Med. 2022;386:1899&#x2013;1909. doi: 10.1056/NEJMoa2202826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2202826</ArticleId><ArticleId IdType="pmc">PMC9006785</ArticleId><ArticleId IdType="pubmed">35353976</ArticleId></ArticleIdList></Reference><Reference><Citation>Starshinova A.A., Malkova A.M., Zinchenko Y.u.S., Kudlay D.A., Glushkova A.V., Dovgalyk I., Yablonskiy P., Shoenfeld Y. Efficacy of different types of therapy for covid-19: A comprehensive review. Life. 2021;11:753. doi: 10.3390/life11080753.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life11080753</ArticleId><ArticleId IdType="pmc">PMC8400016</ArticleId><ArticleId IdType="pubmed">34440497</ArticleId></ArticleIdList></Reference><Reference><Citation>Melekhina E.V., Gorelov A.V., Muzyka A.D. Clinical features of the course of COVID-19 in children of different age groups. Literature review by early April 2020. Quest. Pract. Pediatr. 2020;15:7&#x2013;20. doi: 10.20953/1817-7646-20202-7-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.20953/1817-7646-20202-7-20</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagarro A., Epalza C., Santos M., Sanz-Santaeufemia F.J., Otheo E., Moraleda C., Calvo C. Screening and severity of Coronavirus disease 2019 (COVID-19) in children in Madrid, Spain. JAMA Pediatr. 2021;175:316&#x2013;317. doi: 10.1001/jamapediatrics.2020.1346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2020.1346</ArticleId><ArticleId IdType="pmc">PMC7142799</ArticleId><ArticleId IdType="pubmed">32267485</ArticleId></ArticleIdList></Reference><Reference><Citation>Radia T., Williams N., Agrawal P., Harman K., Weale J., Cook J., Gupta A. Multi-system inflammatory syndrome in children &amp; adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatr. Respir. Rev. 2021;38:51&#x2013;57. doi: 10.1016/j.prrv.2020.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7417920</ArticleId><ArticleId IdType="pubmed">32891582</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste L., Van Paemel R., Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: A systematic review. Eur. J. Pediatr. 2021;180:2019&#x2013;2034. doi: 10.1007/s00431-021-03993-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-03993-5</ArticleId><ArticleId IdType="pmc">PMC7890544</ArticleId><ArticleId IdType="pubmed">33599835</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L., Tang K., Irfan O., Li X., Zhang E., Bhutta Z. Epidemiology, Clinical Features, and Outcomes of Multisystem Inflammatory Syndrome in Children (MIS-C) and Adolescents-a Live Systematic Review and Meta-analysis. Curr. Pediatr. Rep. 2022;10:19&#x2013;30. doi: 10.1007/s40124-022-00264-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40124-022-00264-1</ArticleId><ArticleId IdType="pmc">PMC9072767</ArticleId><ArticleId IdType="pubmed">35540721</ArticleId></ArticleIdList></Reference><Reference><Citation>Irfan O., Muttalib F., Tang K., Jiang L., Lassi Z.S., Bhutta Z. Clinical characteristics, treatment and outcomes of pediatric COVID-19: A systematic review and meta-analysis. Arch. Dis. Child. 2021;106:440&#x2013;448. doi: 10.1136/archdischild-2020-321385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-321385</ArticleId><ArticleId IdType="pmc">PMC8070630</ArticleId><ArticleId IdType="pubmed">33593743</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolinger M.T., Person H., Smith R., Jarchin L., Pittman N., Dubinsky M.C., Lai J. Pediatric Crohn Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated with Infliximab. J. Pediatr. Gastroenterol. Nutr. 2020;71:153&#x2013;155. doi: 10.1097/MPG.0000000000002809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPG.0000000000002809</ArticleId><ArticleId IdType="pmc">PMC7268863</ArticleId><ArticleId IdType="pubmed">32452979</ArticleId></ArticleIdList></Reference><Reference><Citation>Center for Disease Control and Prevention  Multisystem Inflammatory Syndrome in Children (MIS-C)  [(accessed on 18 March 2022)];2021  Available online:  https://www.cdc.gov/mis-c/cases.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention  MIS-C and COVID-19.  [(accessed on 15 January 2022)]; Available online:  https://www.cdc.gov/mis-c/</Citation></Reference><Reference><Citation>Royal College of Pediatrics and Child Health Guidance: Pediatric Multisystem Inflammatory Syndrome Temporally Associated with COVID-19.  [(accessed on 15 January 2022)].  Available online:  https://www.rcpch.ac.uk/resources/paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims-guidance.</Citation></Reference><Reference><Citation>Novikova Y.Y., Ovsyannikov D.Y., Glazyrina A.A., Zhdanova O.I., Zvereva N.N., Karpenko M.A., Kryshova E.S., Kurbanova S.K., Rtishchev A.Y., Sayfullin R.F., et al. Pediatric multisystem inflammatory syndrome associated with novel coronavirus infection COVID-19: Results of a multicenter study. Pediatrics. 2021;100:23&#x2013;31. doi: 10.24110/0031-403X-2021-100-6-23-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.24110/0031-403X-2021-100-6-23-31</ArticleId></ArticleIdList></Reference><Reference><Citation>Belozerov K.E., Kupreeva A.D., Avrusin I.S., Masalova V.V., Kornishina T.L., Isupova E.A., Snegireva L.S., Kalashnikova O.V., Malekov D.A., Pozdnyakov A.V., et al. Cardiac involvement in patients with SARS-CoV-2-associated multisystem inflammatory syndrome: A description of a clinical case series. Pediatrics. 2021;100:35&#x2013;45. doi: 10.24110/0031-403X-2021-100-5-35-45.</Citation><ArticleIdList><ArticleId IdType="doi">10.24110/0031-403X-2021-100-5-35-45</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermolaeva Y.A., Samoilova Y.G., Oleinik O.A., Yun V.E., Kudlay D.A. COVID-19 in children: Generalization of world experience. Pediatrics. 2022;101:80&#x2013;87. doi: 10.24110/0031-403X-2022-101-4-80-87.</Citation><ArticleIdList><ArticleId IdType="doi">10.24110/0031-403X-2022-101-4-80-87</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E., Bamford A., Kenny J., Kaforou M., Jones C., Shah P., Ramnarayan P., Fraisse A., Miller O., Davies P., et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324:259. doi: 10.1001/jama.2020.10369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10369</ArticleId><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Wangu Z., Swartz H., Doherty M. Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination. BMJ Case Rep. 2022;15:e247176. doi: 10.1136/bcr-2021-247176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-247176</ArticleId><ArticleId IdType="pmc">PMC8968554</ArticleId><ArticleId IdType="pubmed">35354564</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlov V.A., Tikhonova E.P., Savchenko A.A., Kudryavtsev I.V., Andronova N.V., Anisimova E.N., Golovkin A.S., Demina D.V., Zdzitovetsky D.E., Kalinina Y.U.S., et al. Clinical Immunology. A Practical Guide for Infectious Disease Specialists. Polikor; Krasnoyarsk, Russia: 2021. 563p</Citation></Reference><Reference><Citation>Kudlay D.A., Shirobokov Y.A.E., Gladunova E.P., Borodulina E.A. Diagnosis of COVID-19. Methods and problems of detecting the SARS-COV-2 virus in a pandemic. Doctor. 2020;31:5&#x2013;10. doi: 10.29296/25877305-2020-08-01.</Citation><ArticleIdList><ArticleId IdType="doi">10.29296/25877305-2020-08-01</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm M., Hartling U.B., Schmidt L.S., Glenth&#xf8;j J.P., Kruse A., Rytter M.H., Lindhard M.S., Lawaetz M.C., Zaharov T., Petersen J.J., et al. Multisystem inflammatory syndrome in children occurred in one of four thousand children with severe acute respiratory syndrome coronavirus 2. Acta Paediatr. 2021;110:2581&#x2013;2583. doi: 10.1111/apa.15985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15985</ArticleId><ArticleId IdType="pmc">PMC8444758</ArticleId><ArticleId IdType="pubmed">34129731</ArticleId></ArticleIdList></Reference><Reference><Citation>Valverde I., Singh Y., Sanchez-de-Toledo J., Theocharis P., Chikermane A., Di Filippo S., Kuci&#xf1;ska B., Mannarino S., Tamariz-Martel A., Gutierrez-Larraya F., et al. AEPC COVID-19 Rapid Response Team*. Acute Cardiovascular Manifestations in 286 Children with Multisystem Inflammatory Syndrome Associated with COVID-19 Infection in Europe. Circulation. 2021;143:21&#x2013;32. doi: 10.1161/CIRCULATIONAHA.120.050065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.050065</ArticleId><ArticleId IdType="pubmed">33166189</ArticleId></ArticleIdList></Reference><Reference><Citation>Valderas C., M&#xe9;ndez G., Echeverr&#xed;a A., Suarez N., Julio K., Sandoval F. COVID-19 and neurological manifestations: A synthesis from the child neurologist&#x2019;s corner. World J. Pediatr. 2022;18:373&#x2013;382. doi: 10.1007/s12519-022-00550-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-022-00550-4</ArticleId><ArticleId IdType="pmc">PMC9044375</ArticleId><ArticleId IdType="pubmed">35476245</ArticleId></ArticleIdList></Reference><Reference><Citation>Balykova L.A., Vladimirov D.O., Krasnopolskaya A.V., Soldatov O.M., Ivyanskaya N.V., Shchekina N.V. Cardiovascular system damage in children with COVID-19. Pediatrics. 2021;100:90&#x2013;98. doi: 10.24110/0031-403X-2021-100-5-90-98.</Citation><ArticleIdList><ArticleId IdType="doi">10.24110/0031-403X-2021-100-5-90-98</ArticleId></ArticleIdList></Reference><Reference><Citation>Noval Rivas M., Porritt R.A., Cheng M.H., Bahar I., Arditi M. Multisystem InflammatorySyndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis. Front. Immunol. 2022;13:941009. doi: 10.3389/fimmu.2022.941009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.941009</ArticleId><ArticleId IdType="pmc">PMC9300823</ArticleId><ArticleId IdType="pubmed">35874696</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho J.S., Sia C.H., Chan M.Y., Lin W., Wong R.C. Coronavirus induced myocarditis: A meta-summary of cases. Heart Lung. 2020;49:681&#x2013;685. doi: 10.1016/j.hrtlng.2020.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2020.08.013</ArticleId><ArticleId IdType="pmc">PMC7440036</ArticleId><ArticleId IdType="pubmed">32861884</ArticleId></ArticleIdList></Reference><Reference><Citation>Gram M.A., Emborg H.D., Schelde A.B., Friis N.U., Nielsen K.F., Moustsen-Helms I.R., Legarth R., Lam J.U.H., Chaine M., Malik A.Z., et al. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study. PLoS Med. 2022;19:e1003992. doi: 10.1371/journal.pmed.1003992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003992</ArticleId><ArticleId IdType="pmc">PMC9436060</ArticleId><ArticleId IdType="pubmed">36048766</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokunbi O., Akinbolagbe Y., Akintan P., Oyeleke G., Kusimo O., Owowo U., Olonade E., Ojo O., Ikhazobor E., Amund O., et al. Clinical presentation and short-term outcomes of multisystemic inflammatory syndrome in children in Lagos, Nigeria during the COVID-19 pandemic: A case series. EClinicalMedicine. 2022;49:101475. doi: 10.1016/j.eclinm.2022.101475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101475</ArticleId><ArticleId IdType="pmc">PMC9156979</ArticleId><ArticleId IdType="pubmed">35747195</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazankova L., Molochkova O.V., Kovalev O., Shamsheva O., Ilyina N., Sakharova A., Galeeva E., Korsunsky A., Luzan P. On the issue of differential diagnosis of bacterial infections and pediatric multisystem inflammatory syndrome during the COVID-19 pandemic. Pediatrics. 2021;100:162&#x2013;167. doi: 10.24110/0031-403X-2021-100-6-162-167.</Citation><ArticleIdList><ArticleId IdType="doi">10.24110/0031-403X-2021-100-6-162-167</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasichkina E., Alekseeva D., Kudryavtsev I., Glushkova A., Starshinova A.Y., Malkova A., Kudlay D., Starshinova A. COVID-19 Heart Lesions in Children: Clinical, Diagnostic and Immunological Changes. Int. J. Mol. Sci. 2023;24:1147. doi: 10.3390/ijms24021147.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021147</ArticleId><ArticleId IdType="pmc">PMC9866514</ArticleId><ArticleId IdType="pubmed">36674665</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>